CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes — Stella

Home/Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes/

View on ClinicalTrials.gov

Recruiting

Back to Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes trials

Trial locations(1 site)

Spain

Vida Recoletas Sevilla S.L., Seville, SEVILLA

Key details

Sponsor

Vida Recoletas Sevilla

Collaborators

University of Seville

Enrollment target

~160 participants

Started

October 2024

Primary completion

June 2026

Age range

18 Years – 45 Years

Sex

Female only

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.